About this episode

The episode discusses ASH 2025 updates on myeloid malignancies with Dr. Curtis Lachowiez.

In this episode, we dive deep into ASH 2025 updates on myeloid malignancies with Dr. Curtis Lachowiez. From the plenary halls of ASH 2025 to long-term follow-up of Aza/Ven/Gilteritinib, we unpack what the latest evidence means for the future of AML management. 1. PARADIGM Trial (Plenary Session, Abstract 6) Fathi A, Perl A, Fell G, et al. Results from PARADIGM – a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia. Blood 2025;146(Suppl 1):6. https://doi.org/10.1182/blood-2025-6 ClinicalTrials.gov: NCT04801797 2. VICEROY Study – Aza/Ven/Gilteritinib Triplet (Abstract 654) Venetoclax (VEN) and azacitidine (AZA) with gilteritinib (GILT) in patients with newly diagnosed FLT3mut+ AML ineligible for intensive induction chemotherapy: Interim results from the phase 1/2 VICEROY study. Blood 2025;146(Suppl 1):654. ClinicalTrials.gov: NCT05520567 3. Long-Term Follow-Up of Aza/Ven/Gilteritinib in FLT3-Mutated AML (Abstract 45) Azevedo RS, et al. Long-term follow-up of azacitidine, venetoclax, and gilteritinib in patients with newly diagnosed FLT3-mutated acute myeloid…

People in this episode

Hosts: Rajshekhar Chakraborty, Ashwin Kishtagari, Edward Cliff

Guest: Dr. Curtis Lachowiez

Topics covered

• myeloid malignancies
• AML management
• clinical trials
• long-term follow-up
• oncology updates

Keywords

• ASH 2025
• myeloid neoplasms
• acute myeloid leukemia
• clinical trials
• venetoclax
• azacitidine
• gilteritinib
• long-term follow-up
• PARADIGM Trial
• VICEROY Study

Mentioned in this episode

Organizations: ASH 2025, PARADIGM Trial, VICEROY Study, J Clin Oncol, Blood

More episodes of Blood Cancer Talks

• Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casulo · January 22, 2026 · 44 min
• Episode 68. ASH 2025 Myeloma Special: MajesTEC-3 and the Bispecific Revolution with Dr. Luciano Costa · January 2, 2026 · 46 min
• Episode 67. Management of CMV in Hematologic Malignancies · November 23, 2025 · 40 min
• Episode 66. International Myeloma Society 2025 Annual Meeting Updates with Dr. Alfred Garfall: The Bispecific Bonanza · October 15, 2025 · 52 min
• Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain · September 24, 2025 · 53 min
• Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson · August 20, 2025 · 43 min

Explore listener stats, chart rankings, contacts and more on the Blood Cancer Talks podcast page.